The Difoprev system constituted by a sock loaded with nanocapsules containing a hydrating agent in the diabetic foot is tested. A total of 30 neuropathic outpatients with foot anhydrosis were randomized into group A, treated with the application of the sock with the nanocapsules, and group B wearing only the socks without the nanocapsules. Patients were blindly evaluated with a clinical score, hygrometry, transepidermal water loss, skin temperature, and skin hardness at baseline and after 6 weeks. No difference between the groups emerged at baseline. Although group B showed no changes at the end of the treatment, group A significantly ( P < .05) improved in all the parameters evaluated. No adverse events were recorded in both groups during the study. The use of hydrating agents carried by nanocapsules-loaded socks is safe and effective for the neuropathic diabetic foot.
Diamant AL, Babey SH, Hastert TA, Brown ERDiabetes. The growing epidemic. Surgeon. 2007 ;5:219-230.
2.
Prompers L., Huijberts M., Apelqvist J., et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50: 18-25.
3.
Boulton AJ, Vileikyte L., Ragnarson-Tenvall G., Apelqvist J.The global burden of diabetic foot disease. Review. Lancet . 2005;366:1719-1724.
4.
Reiber GE, Raugi GJPreventing foot ulcers and amputations in diabetes. Lancet . 2005;366:1695-1703.
5.
Urbancic-Rovan V.Causes of diabetic foot lesions. Lancet. 2005;366:1678-1679.
6.
Pecoraro R.Chronology and determinants of tissue repair in diabetic lower extremity ulcers . Diabetes. 1991; 40:1305-1313.
7.
Low VA, Sandroni P., Fealey RD, Low PADetection of small-fiber neuropathy by sudomotor testing. Muscle Nerve. 2006;34:57-61.
8.
Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy. A population-based study. Diabetes Care. 2004;27:2942-2947.
9.
Yosipovitch G., Hodak E., Vardi P., et al. The prevalence of cutaneous manifestations in IDDM patients and their association with diabetes risk factors and microvascular complications. Diabetes Care. 1998;21:4506-4509.
10.
Sakai S., Kikuchi K., Satoh J., Tagami H., Inoue S.Functional properties of the stratum corneum in patients with diabetes mellitus: similarities to senile xerosis. Br J Dermatol. 2005;153:319-323.
11.
Johnston MV , Pogach L., Rajan M., et al. Personal and treatment factors associated with foot self-care among veterans with diabetes. J Rehabil Res Dev. 2006;43: 227-238.
12.
Muller RH, Petersen RD, Hommoss A., Pardeike J.Nanostructured lipid carriers (NLC) in cosmetic dermal products. Adv Drug Deliv Rev. 2007;59:522-530.
13.
Sung JK, Joung HYCryoprotective properties of exopolysaccaride (p-21653) produced by the Antarctic bacterium, Pseudoalteromonas antarctica KOPRI 21653. J Microbiol . 2007;45:510-514.
14.
Nevot M., Deroncelé V., messner P., Guinea J., Mercadé E.Characterization of outer membrane vesicles released by the psychrotolerant bacterium Pseudoalteromonas antarctica NF3. Environ Microbiol . 2006;8:1523-1533.
15.
de la Maza A., Codech L., Lopez O., Parra JL, Sabes M., Guinea J.Ability of the exopolymer excreted by Pseudoalteromonas antarctica NF3 to coat liposomes and to protect these structures against octyl glucoside. J Biomater Sci Polym Ed. 1999;10:557-572.
16.
de la Maza A., Parra JL, Congregado F., Bozal N., Guinea J.Interaction of the glycoprotein excreted by Pseudoalteromonas antarctica NF3 with phosphatidylcholine liposomes. Colloids Surf A Physicochem Eng Asp. 1998;137: 181-188.
17.
Boulton AJ, Vinik AI, Arezzo JC, et al. American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956-962.
18.
Bilen H., Atmaca A., Akcay G.Neuropad indicator test for the diagnosis of sudomotor function in type 2 diabetes. Adv Ther. 2007;24:1020-1027.
19.
Hoedlftke RD , Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GRRedistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes2001;50:436-443.
20.
Piaggesi A. , Romanelli M., Schipani E., et al. Hardness of plantar skin in diabetic neuropathic feet. J Diabet Complications. 1999;13:129-134.
21.
Pi-Chang S. , Hong-Da L., Shyh-Hua EJ, Yan-Chiou K., Rai-Chi C., Cheng-Kung C.Relationship of skin temperature to sympathetic dysfunction in diabetic at-risk feet. Diabetes Res Clin Pract . 2006;73:41-46.
22.
Levin J., Maibach H.The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release. 2005;103:291-299.
Boulton AJThe diabetic foot: from art to science. The 18th Camillo golgi Lecture. Diabetologia. 2004;47: 1343-1353.
25.
Verdier-Sévrain S., Bonté F.Skin hydration: a review of its molecular mechanisms. J Cosmet Dermatol. 2007; 6:75-82.
26.
Yilmaz E., Borchert H.Effect of lipid-containing, positively charged nanoemulsion on skin hydration, elasticity and erythema - an in vivo study. Int J Pharm. 2006; 307:232-238.
27.
Rojanasakul Y., Wang LY, Bhat M., Glover DD, Malagna CJ, Ma JKH.The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res. 1992;9:1029-1034.
28.
Wu SC, Armstrong DGThe role of activity, adherence, and off-loading on the healing of diabetic foot woundsPlast Reconstr Surg. 2006;117 (suppl 7):248S-253S.
29.
Johnston MV , Pogach L., Rajan M., et al. Personal and treatment factors associated with foot self-care among veterans with diabetes. J Rehabil Res Dev. 2006;43: 227-238.
